Neovasc Inc
TSX:NVCN
Gross Margin
Neovasc Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
|
Neovasc Inc
TSX:NVCN
|
110.5m CAD |
80%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
236.7B USD |
56%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
157.2B USD |
67%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
144B USD |
65%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
144.8B USD |
68%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
121.9B USD |
65%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.9B EUR |
39%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
53.6B USD |
45%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.6B USD |
62%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
43.6B USD |
79%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
284.9B CNY |
59%
|
Neovasc Inc
Glance View
Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures and markets products for the cardiovascular marketplace. The firm's products include the Neovasc ReducerTM (Reducer), for the treatment of refractory angina, a painful and debilitating condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle and the TiaraTM (Tiara), for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. Its wholly owned subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Neovasc Inc's most recent financial statements, the company has Gross Margin of 79.7%.
You don't have any saved screeners yet